CBV is accepting applicants for ASCENT26, a highly curated program built for pre-seed and seed stage
therapeutics companies to gain the strategic clarity needed to achieve investor traction.
Program Overview:
This six-month virtual, cohort-based program has been specifically designed for therapeutics companies to gain foundational and actionable knowledge that can help secure investment.
The program combines weekly expert-led seminars, office hours, personalized coaching from experienced biotech executives, investor ‘test-the-waters’ introductions with feedback, and access to Pitchbook presented by OBIO®.
ASCENT26 culminates with an in-person pitch event attended by investors & biotech executives. Top performing companies are invited to join the CBV portfolio in RIDGE – unlocking access to customized consulting services.
